Retrieved from https://studentshare.org/business/1638372-current-event-paper
https://studentshare.org/business/1638372-current-event-paper.
Current Event Paper: Quality Control Affiliation Quality control is one of the concepts covered in This can be simply defined as the process of evaluating output based on a set standard, and taking the necessary corrective steps if the output fails to meet the set standards. Quality control helps businesses avoid the costs associated with poor quality output which could threaten the survival of the business. In an article by Kana Inagaki appearing in the Wall Street Journal (2014), the author reports of how Daiichi Sankyo has taken steps to improve the quality of its products from Ranbaxy Laboratories.
Daiichi Sankyo is a Japanese pharmaceutical company that has a stake in the Ranbaxy Laboratories based in India. Earlier this year, the US Food and Drug Administration (FAD) had banned the use drugs produced from the laboratory, citing that the drugs have quality problems. In response to this, Daiichi Sankyo has started to put measures in place to improve the quality of products from the laboratory. One f the steps taken is the hiring of consultants and sending experienced employees from Daiichi Sankyo to the Ranbaxy plants.
Furthermore, as reported in the article, the company is taking steps to dig deeper and understand the violations that have led to the poor quality products from the Ranbaxy plants. The main idea behind quality control is to ensure that the output meets the required standards. In the above article, Daiichi Sankyo is taking steps to ensure that the quality of the products from its Ranbaxy plants meets the required international standards. The failure to meet these standards was the reason why the FAD banned the use of its products.
In addition, quality control requires that the company takes the necessary steps to identify the causes of poor quality and how to address them. Daiichi Sankyo is bringing in consultants and experts to help identify and address the quality problems at the Ranbaxy Laboratories.ReferenceInagaki, K (2014, January 31). Daiichi Sankyo Vows Drastic Steps to Improve Ranbaxy Quality. The Wall Street Journal. Retrieved from http://online.wsj.com/news/articles/SB10001424052702303973704579353961389627006
Read More